Table 3. Relative risk of cancer incidence by modeling the cumulative incidence while considering the competing risk of death (Fine and Gray’s subdistribution method).
| Covariate | All cancer | Lung cancer | Colon cancer | Liver Cancer | Breast Cancer | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | |
| CHA2DS2-VASc scores | 0.3208 | 0.4485 | 0.0993 | 0.7814 | 0.8734 | ||||||||||
| 0–2 | ref. | ref. | ref. | ref. | ref. | ||||||||||
| 3–4 | 1.34 | 0.97–1.85 | 0.80 | 0.38–1.71 | 1.95 | 0.84–4.54 | 1.40 | 0.56–3.50 | 1.03 | 0.20–5.27 | |||||
| 5–6 | 1.24 | 0.85–1.81 | 0.88 | 0.40–1.97 | 1.00 | 0.32–3.15 | 1.10 | 0.41–2.97 | 1.70 | 0.24–11.99 | |||||
| 7–9 | 1.14 | 0.70–1.84 | 0.34 | 0.09–1.32 | 2.33 | 0.69–7.89 | 1.69 | 0.52–5.48 | 2.19 | 0.25–19.24 | |||||
| Gender | <0.0001 | 0.0008 | 0.0351 | 0.0009 | |||||||||||
| Female | ref. | ref. | ref. | ref. | |||||||||||
| Male | 2.00 | 1.57–2.56 | 2.71 | 1.51–4.84 | 1.92 | 1.05–3.51 | 4.27 | 1.82–10.03 | |||||||
| Age | <0.0001 | ||||||||||||||
| <65 | ref. | ref. | 0.0123 | ref. | 0.7065 | ref. | 0.0043 | ref. | 0.0719 | ||||||
| 65–74 | 2.24 | 1.58–3.16 | 3.80 | 1.56–9.25 | 1.35 | 0.60–3.05 | 9.39 | 2.26–39.02 | 0.94 | 0.24–3.64 | |||||
| > = 75 | 1.72 | 1.19–2.48 | 2.85 | 1.07–7.58 | 1.10 | 0.44–2.78 | 4.88 | 1.20–19.81 | 0.12 | 0.02–1.03 | |||||